Back to Search
Start Over
Randomized Controlled Trial for Efficacy of Nafamostat Mesilate in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis
- Source :
- Pancreas; April 2015, Vol. 44 Issue: 3 p415-421, 7p
- Publication Year :
- 2015
-
Abstract
- The objective of this study was to investigate whether prophylactic administration of nafamostat mesilate reduces the incidence of post–endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), its efficacy, and risk factors for PEP.
Details
- Language :
- English
- ISSN :
- 08853177 and 15364828
- Volume :
- 44
- Issue :
- 3
- Database :
- Supplemental Index
- Journal :
- Pancreas
- Publication Type :
- Periodical
- Accession number :
- ejs48756667
- Full Text :
- https://doi.org/10.1097/MPA.0000000000000278